Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Arkema S.A. stock logo
ARKAY
Arkema
$70.55
-2.4%
$74.56
$64.94
$102.48
$5.37B1.1115,317 shs8,961 shs
The Berkeley Group Holdings plc stock logo
BKGFY
The Berkeley Group
$11.50
+1.9%
$10.48
$8.48
$15.11
$5.70B1.32257,112 shs75,038 shs
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
$96.20
+18.9%
$88.70
$34.26
$105.60
$1.73B0.25943 shs100 shs
Taylor Wimpey plc stock logo
TWODY
Taylor Wimpey
$16.27
+2.5%
$15.05
$13.05
$23.56
$5.76B1.62167,209 shs474,364 shs
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Arkema S.A. stock logo
ARKAY
Arkema
-2.44%-6.83%-1.27%-17.01%-30.47%
The Berkeley Group Holdings plc stock logo
BKGFY
The Berkeley Group
+0.22%+0.88%+5.50%+18.31%-17.21%
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
+18.90%+18.90%+9.09%+0.43%+208.83%
Taylor Wimpey plc stock logo
TWODY
Taylor Wimpey
+2.55%+3.32%+4.43%+11.59%-12.15%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Arkema S.A. stock logo
ARKAY
Arkema
N/AN/AN/AN/AN/AN/AN/AN/A
The Berkeley Group Holdings plc stock logo
BKGFY
The Berkeley Group
N/AN/AN/AN/AN/AN/AN/AN/A
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
0.0335 of 5 stars
0.01.00.00.01.50.00.0
Taylor Wimpey plc stock logo
TWODY
Taylor Wimpey
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Arkema S.A. stock logo
ARKAY
Arkema
2.50
Moderate BuyN/AN/A
The Berkeley Group Holdings plc stock logo
BKGFY
The Berkeley Group
4.00
Strong BuyN/AN/A
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
4.00
Strong BuyN/AN/A
Taylor Wimpey plc stock logo
TWODY
Taylor Wimpey
2.00
HoldN/AN/A

Current Analyst Ratings Breakdown

Latest PHMMF, BKGFY, ARKAY, and TWODY Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/28/2025
The Berkeley Group Holdings plc stock logo
BKGFY
The Berkeley Group
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Strong-Buy
4/24/2025
Arkema S.A. stock logo
ARKAY
Arkema
Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageUnderperform
(Data available from 5/24/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Arkema S.A. stock logo
ARKAY
Arkema
$10.30B0.52$16.41 per share4.30$107.52 per share0.66
The Berkeley Group Holdings plc stock logo
BKGFY
The Berkeley Group
$3.10B1.84$1.17 per share9.82$8.76 per share1.31
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
$171.15M10.12$0.42 per share231.27$11.62 per share8.28
Taylor Wimpey plc stock logo
TWODY
Taylor Wimpey
$4.37B1.32$2.82 per share5.76N/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Arkema S.A. stock logo
ARKAY
Arkema
$452.40M$4.4814.117.810.533.82%8.04%4.17%8/7/2025 (Estimated)
The Berkeley Group Holdings plc stock logo
BKGFY
The Berkeley Group
$500.02MN/A0.0014.38N/AN/AN/AN/A6/18/2025 (Estimated)
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
$1.23MN/A0.00N/AN/AN/AN/A7/28/2025 (Estimated)
Taylor Wimpey plc stock logo
TWODY
Taylor Wimpey
$433.99MN/A0.0014.27N/AN/AN/AN/A7/30/2025 (Estimated)

Latest PHMMF, BKGFY, ARKAY, and TWODY Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2025Q1 2025
Arkema S.A. stock logo
ARKAY
Arkema
$1.45$1.37-$0.08$0.68$2.44 billion$2.70 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Arkema S.A. stock logo
ARKAY
Arkema
$3.034.30%N/A67.63%N/A
The Berkeley Group Holdings plc stock logo
BKGFY
The Berkeley Group
$0.131.13%N/AN/AN/A
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
N/AN/AN/AN/AN/A
Taylor Wimpey plc stock logo
TWODY
Taylor Wimpey
$1.096.70%N/AN/AN/A

Latest PHMMF, BKGFY, ARKAY, and TWODY Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/20/2025
Arkema S.A. stock logo
ARKAY
Arkema
$3.42744.47%5/22/20255/23/20256/12/2025
3/4/2025
Taylor Wimpey plc stock logo
TWODY
Taylor Wimpey
$0.58963/28/20253/28/20255/23/2025
2/27/2025
The Berkeley Group Holdings plc stock logo
BKGFY
The Berkeley Group
$0.08333/10/20253/10/20254/14/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Arkema S.A. stock logo
ARKAY
Arkema
0.48
2.11
1.54
The Berkeley Group Holdings plc stock logo
BKGFY
The Berkeley Group
0.19
3.46
0.66
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
0.14
2.55
2.01
Taylor Wimpey plc stock logo
TWODY
Taylor Wimpey
N/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Arkema S.A. stock logo
ARKAY
Arkema
N/A
The Berkeley Group Holdings plc stock logo
BKGFY
The Berkeley Group
N/A
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
N/A
Taylor Wimpey plc stock logo
TWODY
Taylor Wimpey
N/A

Insider Ownership

CompanyInsider Ownership
Arkema S.A. stock logo
ARKAY
Arkema
N/A
The Berkeley Group Holdings plc stock logo
BKGFY
The Berkeley Group
N/A
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
1.88%
Taylor Wimpey plc stock logo
TWODY
Taylor Wimpey
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Arkema S.A. stock logo
ARKAY
Arkema
21,10076.06 millionN/ANot Optionable
The Berkeley Group Holdings plc stock logo
BKGFY
The Berkeley Group
3,030495.33 millionN/ANot Optionable
Pharma Mar, S.A. stock logo
PHMMF
Pharma Mar
50918.01 millionN/ANot Optionable
Taylor Wimpey plc stock logo
TWODY
Taylor Wimpey
5,236354.13 millionN/ANot Optionable

Recent News About These Companies

Taylor Wimpey warns of profit margin squeeze in first half
Taylor Wimpey recovery in focus as margins set to trough
Taylor Wimpey flags cost pressures after Budget
UK economy, Taylor Wimpey, Premier Inn owner in focus on Thursday
Taylor Wimpey needs to distance itself from sector malaise
TWODY Taylor Wimpey plc
Taylor Wimpey steadies housebuilding nerves with update
Taylor Wimpey: The Ship Has Sailed (Rating Downgrade)
Taylor Wimpey plc goes ex dividend today
Developer told it must build affordable homes
Wallenius Wilhelmsen ASA (WILWY)

New MarketBeat Followers Over Time

Media Sentiment Over Time

Arkema stock logo

Arkema OTCMKTS:ARKAY

$70.55 -1.77 (-2.44%)
As of 05/23/2025 03:20 PM Eastern

Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets. This segment also offers performance polymers, such as specialty polyamides, PVDF, polyimides, fluorospecialties, and polyetherketoneketone; and performance additives which includes molecular sieves, organic peroxides, thiochemicals, and hydrogen peroxide. The Advance Materials and Coating Solutions segment offers coating solutions, including comprising EU/US acrylics and coating resins; coating additives, such as sartomer photocure resins and coatex rheology additives. This segment also provides decorative paints, industrial coatings, and adhesives; and solutions for applications in the paper, superabsorbent, water treatment and oil and gas extraction, and 3D printing and electronics industries. The Intermediates segment provides fluorogases and acrylics; and industrial intermediate chemicals used in construction, refrigeration and air conditioning, automotive, coatings, and water treatment sectors. Arkema S.A. was incorporated in 2003 and is headquartered in Colombes, France.

The Berkeley Group stock logo

The Berkeley Group OTCMKTS:BKGFY

$11.50 +0.21 (+1.86%)
As of 05/23/2025 03:59 PM Eastern

The Berkeley Group Holdings plc, together with its subsidiaries, engages in the residential-led and mixed-use property development and ancillary activities in the United Kingdom. The company is involved in land selling activities. It operates under the Berkeley, St Edward, St George, St James, St Joseph, and St William brand names. The Berkeley Group Holdings plc was founded in 1976 and is headquartered in Cobham, the United Kingdom.

Pharma Mar stock logo

Pharma Mar OTCMKTS:PHMMF

$96.20 +15.29 (+18.90%)
As of 05/23/2025 10:21 AM Eastern

Pharma Mar, S.A., a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments. It develops and commercializes Yondelis for the treatment of soft tissue sarcoma and for ovarian cancer; Aplidin for treating R/R multiple myeloma; and Zepzelca to treat patients with small cell lung cancer. The company develops Ecubectedin (PM14), which is in phase II clinical trials for the treatment of solid tumors, as well as in Phase I clinical trials for the treatment of soft tissue sarcoma and prostate cancer; PM534 that is Phase I clinical trials for treating solid tumors; PM54, which is in Phase I clinical trials for the treatment of solid tumors; SYL1801 that is in phase II clinical trials for treating macular degeneration; SYL116011, which is in preclinical studies for the treatment of ocular allergies; and SYL A and B that is in investigational studies to treat retinitis pigmentosa. In addition, it engages in the research, development, production, and sale of products with therapeutic activity based on reducing or silencing gene expression. Pharma Mar, S.A. was incorporated in 1986 and is based in Madrid, Spain.

Taylor Wimpey stock logo

Taylor Wimpey OTCMKTS:TWODY

$16.27 +0.40 (+2.55%)
As of 05/23/2025 03:59 PM Eastern

Taylor Wimpey plc operates as a homebuilder in the United Kingdom and Spain. It builds and delivers various homes and communities. Taylor Wimpey plc was incorporated in 1935 and is based in High Wycombe, the United Kingdom.